FACULTAD DE FARMACIA
Facultad
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (81)
2024
-
Versican accumulation drives Nos2 induction and aortic disease in Marfan syndrome via Akt activation
EMBO molecular medicine, Vol. 16, Núm. 1, pp. 132-157
2023
-
Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 184, pp. 103-115
-
GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors
American Journal of Psychiatry
2022
-
Clinical improvements after treatment with a low-valine and low-fat diet in a pediatric patient with enoyl-CoA hydratase, short chain 1 (ECHS1) deficiency
Orphanet journal of rare diseases, Vol. 17, Núm. 1, pp. 340
-
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia
Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919
-
Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors
Biological psychiatry, Vol. 91, Núm. 3, pp. 313-327
-
Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS
Analytical Methods, Vol. 14, Núm. 43, pp. 4359-4369
-
Monocyte-to-Lymphocyte Ratio in Clot Analysis as a Marker of Cardioembolic Stroke Etiology
Translational Stroke Research, Vol. 13, Núm. 6, pp. 949-958
-
The Effect of Body Fat Distribution on Systemic Sclerosis
Journal of Clinical Medicine, Vol. 11, Núm. 20
-
Tracking the physicochemical stability of teduglutide (Revestive®) clinical solutions over time in different storage containers
Journal of Pharmaceutical and Biomedical Analysis, Vol. 221
2021
-
Bipolar multiplex families have an increased burden of common risk variants for psychiatric disorders
Molecular Psychiatry, Vol. 26, Núm. 4, pp. 1286-1298
-
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes
Annals of the Rheumatic Diseases, Vol. 80, Núm. 8, pp. 1040-1047
-
Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology
Nature genetics, Vol. 53, Núm. 6, pp. 817-829
-
Genomic Risk Score impact on susceptibility to systemic sclerosis
Annals of the Rheumatic Diseases, Vol. 80, Núm. 1, pp. 118-127
-
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
Journal of Biomedical Science, Vol. 28, Núm. 1
2020
-
Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci
Genome Medicine, Vol. 12, Núm. 1
-
Radiological and surgical differences between congenital end-to-side (Abernethy malformation) and side-to-side portocaval shunts
Journal of Pediatric Surgery, Vol. 55, Núm. 9, pp. 1897-1902
2019
-
Association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis-related calcinosis
Rheumatology (United Kingdom)
-
Endotipsitis as an indication for pediatric liver transplantation
Transplant Infectious Disease, Vol. 21, Núm. 4
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1